Skip to content
All Sections
Subscribe Now
72°F
Tuesday, July 23rd 2024
e-Edition
Home Page
Close Menu
News
News
Crime and Public Safety
Investigative Reporting
Politics
Health
Environment
Business
Best Reviews
Housing
Jobs
Local News
Local News
Long Beach
Los Angeles
Los Angeles County
Sports
Sports
High School Sports
Chargers
Rams
Lakers
Clippers
Dodgers
Angels
College Sports
UCLA Sports
USC Sports
Long Beach State sports
Kings
Ducks
Olympics
Boxing/MMA
Soccer
Horse Racing
Things To Do
Things To Do
Restaurants Food and Drink
Movies
Music + Concerts
Theater
TV and Streaming
Home + Garden
Travel
Amusement Parks
Comics
Puzzles
Events
Obituaries
Obituaries
News Obituaries
Place an Obituary
Opinion
Opinion
Editorials
Opinion Columns
Commentary
Letters to the Editor
Editorial Board
Endorsements
The Grunion
The Grunion
News
Education
Sports
Things to Do
Opinion
E-Edition
Advertising
Contact Us
SCNG Premium
The T.E.A.
Subscribe
Press-Telegram Store
Log In
Logout
Close Menu
Get the latest news delivered daily!
Sign Up
Subscribe
Log In
Account Settings
Contact Us
Log Out
Spoof a user
Get the latest news delivered daily!
Sign Up
Subscribe
Log In
Search
Press Telegram
72°F
Tuesday, July 23rd 2024
e-Edition
News
Local News
Sports
Things to Do
Obituaries
Opinion
The T.E.A.
Trending:
Biden drops out of race
Project 2025's impact in CA
Homeless pet food pantry opens
SpaceX moving to Texas
LB Burger Week ð
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Seres Therapeutics, Inc.
< Previous
1
2
3
Next >
Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
May 08, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 06, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics to Announce First Quarter 2024 Financial Results and Business Update on May 8, 2024
May 06, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
April 09, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 28, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 19, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
March 05, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics to Host Fourth Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on March 5, 2024
February 28, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference
February 27, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Announces the Appointment of Marella Thorell as Chief Financial Officer and the Retirement of David Arkowitz
February 26, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 17, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Announces VOWST™ Commercial Launch Update and US FDA Fast Track Designation for SER-155
January 09, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
January 04, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Announces Presentation of Preliminary PK/PD and Safety Data for Investigational Microbiome Therapeutic SER-155 at ASH 2023
December 07, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023; Webcast at 3:30 p.m. ET
November 28, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Reports Third Quarter 2023 Financial Results Including VOWST™ Net Sales of $7.6 Million
November 02, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics to Announce Third Quarter 2023 Results on Thursday, November 2, 2023; Host Conference Call and Webcast at 8:00 a.m. EST
October 30, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics to Highlight VOWST™ Data at IDWeek
October 12, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 06, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 08, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
September 07, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
August 08, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 04, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics to Present at Canaccord Genuity 43rd Annual Growth Conference
August 01, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics to Host Second Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on August 8, 2023
August 01, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 14, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Named to TIME100 Most Influential Companies List
June 21, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics and Nestlé Health Science Present Late-Breaking Data on VOWST™, a Microbiota-Based Oral Therapeutic for Prevention of Recurrence of C. Difficile Infection in Adults, at ASM Microbe 2023
June 17, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics to Present at Goldman Sachs Global Healthcare Conference
June 09, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 09, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Tickers
MCRB
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close